Neuroimaging Reveals Treatment-related Changes in DLD

May 20, 2026 updated by: Karla Washington, University of Cincinnati
Children with developmental language disorders (DLD, aka specific language impairment), a prevalent pediatric disorder, experience hallmark grammar deficits with life-long impacts on educational and occupational outcomes. While effective and early interventions can mitigate the impact of DLD, not enough is known about the neural basis of DLD in young children, yet is needed to inform the design of more individualized interventions. This project uses neuroimaging, along with behavioral methods, with the goal of better understanding the memory-language mechanisms that underlie grammar learning and impairment, while also considering their association to treatment-related changes in preschoolers with DLD.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Although the impact of developmental language disorder (DLD), a prevalent preschool disorder, can be mitigated through evidence-based and early interventions, little is known about the neural basis of DLD, especially in young children, yet is useful in the design of efficacious treatments. While much of the evidence has been furnished by studies examining domain-specific processes (language network), domain-general processes relating memory and language also offer valuable testing ground and present the opportunity to advance the current knowledge base. The Procedural circuit Deficit Hypothesis (PDH) posits that grammar deficits are explained by an impairment of procedural memory (rule learning, "knowing how"). This impairment is associated with structural abnormalities in connections between frontal brain regions and basal ganglia, with corresponding underactivation and reduced functional connectivity. However, the declarative memory system (semantic, "knowing what"), supported by cortical and subcortical regions in the temporal lobes, including hippocampus, is spared, acting as a compensatory mechanism to offset grammar deficits.

This proposed research will use neuroimaging (functional MRI and diffusion imaging) to describe the neural basis (functional and structural connectivity) of grammar learning and treatment-related change by way of the PDH. The investigators will gather critical data regarding grammar learning in preschoolers with DLD before, after, and following a break in intervention (computer-assisted treatment: DLD treatment; "business as usual": DLD no treatment) as part of a randomized controlled trial. The investigators will also include typically developing (TD) peers to inform development vs disorder. Our central hypothesis is that treatment designed to improve grammar learning will normalize the procedural learning network in association with increases in language function and that the degree of improvement may be associated with the underlying neurobiology of baseline grammar deficits.

Building on a robust history of recruitment and treatment of preschoolers with DLD, the investigators will enroll 184 preschoolers, 100 with DLD (n=50 treatment; n=50 no treatment controls) and 84 TD. Aim 1 will establish the relationship between functional and structural connectivity for preschoolers with DLD and their TD peers between regions in the procedural learning and declarative networks. In Aim 2, the investigators will establish the neurobiological basis of treatment-related changes in DLD only. The investigators examine potential changes in functional and structural connectivity between regions of the procedural learning and declarative memory networks, and investigate whether treatment-related changes occur into the typical range (DLD and TD). To meet our scientific goals, the investigators pair behavioral tools (traditional grammar tools) with neuroimaging to describe co-occurring behavioral performance underlying learning and outcome. This research will contribute novel insights into mechanisms underlying learning and impairment to help advance the evidence-based management of DLD.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ohio
      • Cincinati, Ohio, United States, 45207
        • Not yet recruiting
        • New Horizon Childcare
        • Contact:
      • Cincinnati, Ohio, United States, 45267
      • Cincinnati, Ohio, United States, 45229
        • Not yet recruiting
        • Cincinnati Children's Hospital
        • Contact:
      • Cincinnati, Ohio, United States, 45220
      • Cincinnati, Ohio, United States, 45229
      • Cincinnati, Ohio, United States, 45229
        • Recruiting
        • Wesley Education Center for Children and Families
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 5 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • ages 48-71 months
  • average nonverbal intelligence quotient (IQ)
  • enrolled in participating center
  • typically developing (receptive and expressive language, social, articulation, other)
  • DLD for expressive grammar
  • typical oral motor function
  • typical social/pragmatics skills
  • average hearing thresholds
  • monolingual and native Standard English speakers
  • does not have any uncorrected vision challenges

Exclusion Criteria:

  • receiving co-occurring speech-language or other intervention for communication
  • not MRI safe
  • special education placement of child based on ability or behavior

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment
computer assisted intervention targeting expressive grammar for preschoolers with DLD
computer-assisted treatment program for expressive grammar
No Intervention: No treatment
business as usual classroom (educational) services

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional connectivity data (time 1) from typical and DLD preschoolers
Time Frame: Time 1 (pre)
Aim 1 (all TD and DLD preschoolers)- Primary: Pre/Time 1 data for functional connectivity (assessed using fMRI from the Sentence Completion Expressive Language Task- Preschool (SCELT-P)) between Regions of Interest (ROI) in the procedural learning network and in the declarative memory network
Time 1 (pre)
Functional connectivity data DLD preschoolers only to assess changes with treatment
Time Frame: Pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Primary: Pre-to-post changes and maintenance of changes post-to-followup in functional connectivity (assessed using fMRI from the SCELT-P) between ROI within the procedural learning network and within the declarative memory network.
Pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Functional connectivity data for typically developing and DLD preschoolers to assess changes in development
Time Frame: pre-to-follow-up (up to 28 weeks)
Changes in development (pre-to-followup) in functional connectivity (assessed using fMRI from the SCELT-P) between ROI within the procedural learning and declarative memory networks.
pre-to-follow-up (up to 28 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Structural connectivity data for typically developing and DLD preschoolers
Time Frame: Pre/Time 1 (up to 3-weeks)
Main Secondary: structural connectivity (assessed using diffusion imaging) between anatomically-selected ROI in the procedural learning and declarative memory networks
Pre/Time 1 (up to 3-weeks)
Structural connectivity data for DLD preschoolers only to assess changes with treatment
Time Frame: pre-to-post (up to 14-weeks) and post-to-follow-up (at 27 to 28 weeks)
Main Secondary Pre-to-post changes and maintenance of changes post-to-followup in structural connectivity (assessed using diffusion imaging) between anatomically-selected ROI in the procedural learning network and declarative memory network
pre-to-post (up to 14-weeks) and post-to-follow-up (at 27 to 28 weeks)
Structural connectivity data for typically developing and DLD preschoolers to assess development and disorder over time.
Time Frame: pre-to-followup (up to 28-weeks)
Main Secondary: Changes in development (pre-to-followup) in structural connectivity (assessed using diffusion imaging) between anatomically-selected ROI in the procedural learning network and in the declarative memory network
pre-to-followup (up to 28-weeks)
Percent correct on a grammar task for typically developing and DLD preschoolers to assess development and disorder.
Time Frame: Pre/Time 1 (up to 3-weeks)
Additional secondary outcomes raw score on the PI-designed 45-item grammar probe (%correct for each of the three target forms, 15-forms per target). Scores are combine to get a total score on the task
Pre/Time 1 (up to 3-weeks)
Raw score on the SPELT-3 for typically developing and DLD preschoolers to assess development
Time Frame: Pre/Time 1 (up to 3-weeks)
Additional secondary outcomes raw score a standard grammar test (SPELT-3)
Pre/Time 1 (up to 3-weeks)
Raw score on the DSS for typically developing and DLD preschoolers to assess development
Time Frame: Pre/Time 1 (up to 3-weeks)
Additional secondary outcomes raw score a standard play based task (DSS) to assess development and disorder
Pre/Time 1 (up to 3-weeks)
Percent correct on a grammar screener for DLD preschoolers only to identify treatment targets
Time Frame: Pre/Time 1 (up to 3-weeks)
Additional secondary outcomes: raw change score on the PI-designed grammar probe
Pre/Time 1 (up to 3-weeks)
Percent correct on a grammar task for DLD preschoolers only
Time Frame: Pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Additional secondary outcomes raw score on the PI-designed 45-item grammar probe (%correct for each of the three target forms, 15-forms per target). Scores are combine to get a total score on the task.
Pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Raw score on the SPELT-3 for DLD preschoolers only to assess change with treatment
Time Frame: Pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Additional secondary outcomes raw score a standard grammar test (SPELT-3)
Pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Raw score on the DSS for DLD preschoolers only to assess change with treatment
Time Frame: Pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Additional secondary outcomes raw score a standard play based task (DSS) to assess changes with treatment
Pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Percent correct on a grammar task for typically developing and DLD preschoolers to assess development and disorder.
Time Frame: pre-to-followup (up to 28-weeks)
Additional secondary outcomes raw score on the PI-designed 45-item grammar probe (%correct for each of the three target forms, 15-forms per target). Scores are combine to get a total score on the task
pre-to-followup (up to 28-weeks)
Raw score on the SPELT-3 for typically developing and DLD preschoolers to assess development
Time Frame: pre-to-followup (up to 28-weeks)
Additional secondary outcomes raw score a standard grammar test (SPELT-3)
pre-to-followup (up to 28-weeks)
Raw score on the DSS for typically developing and DLD preschoolers to assess development
Time Frame: pre-to-followup (up to 28-weeks)
Additional secondary outcomes raw score a standard play based task (DSS) to assess development and disorder
pre-to-followup (up to 28-weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karla N Washington, PhD, University of Cincinnati

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2022

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

February 10, 2022

First Submitted That Met QC Criteria

March 2, 2022

First Posted (Actual)

March 7, 2022

Study Record Updates

Last Update Posted (Actual)

May 26, 2026

Last Update Submitted That Met QC Criteria

May 20, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Developmental Language Disorder

Clinical Trials on My Sentence Builder

Subscribe